Heart failure & cardiomyopathies

Prevalence of Transthyretin Cardiac Amyloidosis in Undifferentiated Heart Failure with Preserved Ejection Fraction

ESC Heart FailPublished Prospective cross-sectional screening study

Authors' conclusion

In an undifferentiated HFpEF cohort, 8% were found to have wild-type ATTR-CM using a DPD scintigraphy-based screening protocol.

Study context

Population
Patients with heart failure with preserved ejection fraction (HFpEF) (ejection fraction (EF) ≥50%) aged ≥60 years, no prior evaluation for cardiac amyloidosis or known monoclonal gammopathy
Participants
86 patients
Exposure
DPD scintigraphy-positive vs DPD scintigraphy-negative
  • DPD-positiven = 7
Outcome
Prevalence of ATTR-CM by DPD scintigraphy-based screening
Methodological detailsregional cardiology network
  • Regional cardiology network

Main finding

As reported in the abstract

Prevalence of wild-type ATTR-CM

DPD-positive

8%

7

Observational data: associations, not effects.

Further findings

Age

Male sex

P = 0.02

LV wall thickness

P = 0.002

High-sensitivity troponin at diagnosis

P < 0.001

Original publication

Prevalence of Transthyretin Cardiac Amyloidosis in Undifferentiated Heart Failure with Preserved Ejection Fraction. ESC Heart Fail. Published 7 November 2024. doi:10.1002/ehf2.15112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.